2
Clinical Trials associated with NKG2D CAR-NK(Zhejiang Provincial People's Hospital)Prospective clinical study of NKG2D CAR-NK combined with PD-1 monoclonal antibody in the treatment of anaplastic thyroid carcinoma (ATC)
/ Not yet recruitingPhase 1/2IIT Clinical Exploratory Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of Anaplastic Thyroid Cancer (ATC)
The patients with anaplastic thyroid cancer were treated with CAR-NK immune cells combined with PD-1 monoclonal antibody, and the safety and tolerability of the patients were observed and evaluated.
100 Clinical Results associated with NKG2D CAR-NK(Zhejiang Provincial People's Hospital)
100 Translational Medicine associated with NKG2D CAR-NK(Zhejiang Provincial People's Hospital)
100 Patents (Medical) associated with NKG2D CAR-NK(Zhejiang Provincial People's Hospital)
100 Deals associated with NKG2D CAR-NK(Zhejiang Provincial People's Hospital)